Physicians' Knowledge About FDA Approval Standards and Perceptions of the "Breakthrough Therapy" Designation.
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, Massachusetts.
Aaron S
AS
Kesselheim
Center for Medicine and the Media, Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, New Hampshire3Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
Steven
S
Woloshin
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, Massachusetts.
Wesley
W
Eddings
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, Massachusetts.
Jessica M
JM
Franklin
American Board of Internal Medicine, Philadelphia, Pennsylvania.
Kathryn M
KM
Ross
Center for Medicine and the Media, Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, New Hampshire3Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
Lisa M
LM
Schwartz
D016001:Confidence Intervals; D004059:Diffusion of Innovation; D017277:Drug Approval / Q000379:methods*; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D007388:Internal Medicine / Q000706:statistics & numerical data; D008297:Male; D008875:Middle Aged; D010820:Physicians; D013038:Specialization / Q000706:statistics & numerical data; D011795:Surveys and Questionnaires; D014481:United States; D014486:United States Food and Drug Administration